This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ferring B.v.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Mark Andrew Whitaker: Pharmaceutical Formulation Inventor
Introduction
Mark Andrew Whitaker is an inventor associated with Nottingham, Great Britain, and Ferring B.V. His work includes a patent concerning biodegradable polymer formulations for delivering gonadotropin-releasing hormone and related compounds.
Latest Patents
Whitaker is listed as an inventor on 1 patent: “Microparticles Comprising GnRH Made by PGSS.” The patent describes a pharmaceutical formulation with a solid matrix made from one or more biodegradable polymers. A pharmaceutically active substance, or an acceptable salt of that substance, is distributed homogeneously or substantially homogeneously within the matrix. Examples include gonadotropin-releasing hormone (GnRH), GnRH agonists, and GnRH antagonists.
Career Highlights
Whitaker’s listed patent reflects work in pharmaceutical formulation and drug-delivery technologies. The invention focuses on incorporating active substances into biodegradable polymer matrices.
Collaborations
Whitaker’s listed coworkers include Gregoire Charles Joseph Schwach and Lars Schiefelbein. The patent is associated with Ferring B.V.
Conclusion
Mark Andrew Whitaker’s patent work centers on biodegradable microparticle formulations designed to deliver GnRH and related pharmaceutical compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
